Guo Zhigang, Zhang Yalin, Wang Huimin, Li Bo
Medical School, Huanghe Science and Technology College, Zhengzhou, China.
Ann Palliat Med. 2023 Jan;12(1):171-180. doi: 10.21037/apm-22-1364.
Unilateral double-port endoscopic (UBE) discectomy is a newly invented surgical procedure for the treatment of lumbar disc herniation (LDH). As it has been on the market for a relatively short period of time, the lack of systematic analysis of the clinical efficacy and safety of the treatment of LDH is unclear. In this study, we compare randomised controlled trials to assess the clinical efficacy and safety of UBE and conventional endoscopic discectomy for LDH.
The Chinese National Knowledge Infrastructure, Wanfang, PubMed, Embase, Cochrane library, and Chinese Biomedical databases were searched (from database inception to October 2022). The quality of included studies was assessed according to the Cochrane Risk Manual. The intervention of the UBE group was UBE discectomy, and the control measure was conventional endoscopic discectomy. The outcome indicators included hospital stay, the visual analogue score (VAS), intraoperative bleeding, the Oswestry dysfunction index (ODI), and complications. The data were analyzed using RevMan 5.4.
In total, 7 studies were included. Intraoperative bleeding was higher in the control group than in the UBE group (MD =-0.07; 95% confidence interval (CI): -0.21 to 0.08; P=0.14). The improvement of ODI score in the UBE group was significantly better (MD =0.13, 95% CI: -0.06 to 0.32; P=0.17). There was no statistical heterogeneity in terms of postoperative complications (I2=0%, P=1.00). The complication rate in the UBE group was lower (MD =0; 95% CI: -0.15 to 0.15; P=1.00). Postoperative VAS improvement in UBE group was significantly better (MD =-0.12; 95% CI: -0.27 to 0.03; P=0.11). The length of hospital stay in UBE group was shorter (MD =-2.04; 95% CI: -2.23 to -1.84; P<0.05). The t value of hospitalization length, VAS, intraoperative bleeding, ODI and complications were 0.000-0.081, v was 20-26, all P>0.05, suggesting that this conclusion was stable.
Patients in the UBE group spent less time in the hospital than the control group, and UBE group patients also woke up earlier than the control group. Therefore, UBE discectomy has certain reference value and can be popularized in clinic.
单侧双通道内镜下(UBE)椎间盘切除术是一种新发明的用于治疗腰椎间盘突出症(LDH)的外科手术。由于其上市时间相对较短,对其治疗LDH的临床疗效和安全性缺乏系统分析尚不清楚。在本研究中,我们比较随机对照试验以评估UBE和传统内镜下椎间盘切除术治疗LDH的临床疗效和安全性。
检索中国国家知识基础设施、万方、PubMed、Embase、Cochrane图书馆和中国生物医学数据库(从数据库建立至2022年10月)。根据Cochrane风险手册评估纳入研究的质量。UBE组的干预措施为UBE椎间盘切除术,对照措施为传统内镜下椎间盘切除术。结局指标包括住院时间、视觉模拟评分(VAS)、术中出血、Oswestry功能障碍指数(ODI)和并发症。使用RevMan 5.4分析数据。
共纳入7项研究。对照组术中出血高于UBE组(MD=-0.07;95%置信区间(CI):-0.21至0.08;P=0.14)。UBE组ODI评分改善明显更好(MD=0.13,95%CI:-0.06至0.32;P=0.17)。术后并发症方面无统计学异质性(I²=0%,P=1.00)。UBE组并发症发生率更低(MD=0;95%CI:-0.15至0.15;P=1.00)。UBE组术后VAS改善明显更好(MD=-0.12;95%CI:-0.27至0.03;P=0.11)。UBE组住院时间更短(MD=-2.04;95%CI:-2.23至-1.84;P<0.05)。住院时间、VAS、术中出血、ODI和并发症的t值为0.000-0.081,v为20-26,均P>0.05,表明该结论稳定。
UBE组患者住院时间比对照组短,且UBE组患者比对照组苏醒更早。因此,UBE椎间盘切除术有一定参考价值,可在临床推广。